ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $988,689 | -71.8% | 97,600 | -72.5% | 0.00% | -75.0% |
| Q3 2022 | $3,505,000 | -35.9% | 354,397 | -31.0% | 0.01% | -27.3% |
| Q2 2022 | $5,472,000 | -19.2% | 513,710 | +51.9% | 0.01% | -60.7% |
| Q3 2021 | $6,776,000 | +12.7% | 338,120 | +23.7% | 0.03% | +3.7% |
| Q2 2021 | $6,011,000 | +249.5% | 273,279 | +439.6% | 0.03% | +237.5% |
| Q1 2021 | $1,720,000 | -91.7% | 50,641 | -90.1% | 0.01% | -92.9% |
| Q4 2020 | $20,620,000 | – | 512,410 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |